[ad_1]
NEW YORK–(BUSINESS DATE)–Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Accelerate Diagnostics, Inc. (“Accelerate Diagnostics” or the “Company”) (NASDAQ: AXDX) on behalf of stockholders of Accelerate Diagnostics. . Our investigation concerns whether Accelerate Diagnostics violated the federal securities laws and/or engaged in other illegal business practices.
Click here to get in on the action.
After the market closed on October 21, 2022, Accelerate Diagnostics disclosed receiving a request from the US Food and Drug Administration for the company to immediately cease marketing and distribution of its Accelerate Arc system and associated BC Kit for particular diagnostic use.
Previously, Accelerate Diagnostics marketed Accelerate Arc’s products as Class I devices, exempting them from 510(k) clearance requirements. Recently, the FDA informed the company that marketing the products in the United States requires 510(k) clearance.
Shares of Acceler Diagnostics shares fell about 9% in premarket trading and fell more than 40% in intraday trading on October 24, 2022.
If you purchased or otherwise acquired shares of Accelerate Diagnostics and suffered a loss, are a long-time shareholder, have information, would like to learn more about these claims, or have questions about this announcement or your rights or interests with respect to these matters. , please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, by phone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, PC:
Bragar Eagel & Squire, PC is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivatives and other complex litigation in state and federal courts across the country. For more information about the company, please visit www.bespc.com. Lawyer advertising. Previous results do not guarantee similar results.
[ad_2]
Source link